Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 2,505 | 2,689 | 2,786 | 3,089 | 3,150 |
| Operating Income | -2,505 | -2,689 | -2,786 | -3,089 | -3,150 |
| Interest Expense | 6 | 124 | 94 | 111 | 72 |
| Other Income | 84 | -145 | -1,286 | 80 | 1 |
| Pre-tax Income | -2,427 | -2,958 | -4,166 | -3,120 | -3,221 |
| Net Income Continuous | -2,427 | -2,958 | -4,166 | -3,120 | -3,221 |
| Net Income | $-2,427 | $-2,958 | $-4,166 | $-3,120 | $-3,221 |
| EPS Basic Total Ops | -0.89 | -4.00 | 3.76 | -11.91 | -16.86 |
| EPS Basic Continuous Ops | -0.89 | -4.00 | 3.76 | -11.89 | -16.86 |
| EPS Diluted Total Ops | -0.89 | -4.00 | 3.76 | -11.91 | -16.86 |
| EPS Diluted Continuous Ops | -0.89 | -4.00 | 3.76 | -11.89 | -16.86 |
| EPS Diluted Before Non-Recurring Items | N/A | -4.00 | N/A | -11.91 | -16.83 |
| EBITDA(a) | $-2,484 | $-2,602 | $-2,715 | $-3,006 | $-3,150 |